ADAM12 and nonpapillary renal cell carcinoma: Moreover, the transwell assay revealed that the invasive capacity of ccRCC cells was inhibited or strengthened after depletion or restoration of ADAM12 in ccRCC cells, respectively (Fig. 3C, D).